Soooooooo......the company outlines a calc that nominates funding for exactly 12.6 quarters, they states that the calc is not consistent with reality......and then...........
......well and then nothing.
What a freaking joke. Do they have any idea what they are going to spend? Talking up A$11.2M and (one assumes) not yet enrolled a candidate in a FDA P2 trial, FULLY FUNDED by the company - it seems they want they don't know or they prefer the market work out how much it will cost???!!!
I'll be watching. So will the BoDs, it seems.
Ann: Quarterly Activity Report & Appendix 4C, page-14
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.70M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9318 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 2157 | 1 |
View Market Depth
| Last trade - 10.02am 18/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable
